Multimodality Treatment for Bladder Conservation

Ott O (2019)


Publication Type: Authored book

Publication year: 2019

Publisher: Springer International Publishing

ISBN: 9783319426235

DOI: 10.1007/978-3-319-42623-5_24

Abstract

Standard treatment for muscle-invasive urothelial cancer of the bladder is radical cystectomy. Multimodality treatment, including initial transurethral resection of the bladder tumor (TUR-B), followed by concurrent radiochemotherapy (RCT) has been shown to produce survival rates comparable to those of radical cystectomy. With these bladder conservation approaches, (salvage) cystectomy has been reserved for patients with incomplete response or local muscle-invasive relapse. During the past three decades, organ preservation by multimodality treatment has been investigated in prospective series from single centers and cooperative groups, with far more than 1000 patients included. Five-year overall survival rates in the range of 50–60% have been reported, and approximately 80% of the surviving patients maintained their own bladder. Clinical criteria helpful in determining patients for bladder preservation include such variables as small tumor size (<5 cm), early tumor stage, a visibly and microscopically complete transurethral resection, absence of ureteral obstruction, and no evidence of pelvic lymph node metastases. On multivariate analysis, the completeness of TUR-B was found to be one of the strongest predictive factors for overall survival. Patients at greater risk of recurrence after initial complete response are those with multifocal disease and extensive associated carcinoma in situ at presentation. Close coordination among all disciplines is required to achieve optimal results. Future investigations will focus on optimizing radiation techniques including all possibilities of radiosensitization (e.g., concurrent radiochemotherapy, additional deep regional hyperthermia), and incorporating more effective systemic chemotherapy, and proper selection of patients based on predictive molecular makers.

Authors with CRIS profile

How to cite

APA:

Ott, O. (2019). Multimodality Treatment for Bladder Conservation. Springer International Publishing.

MLA:

Ott, Oliver. Multimodality Treatment for Bladder Conservation. Springer International Publishing, 2019.

BibTeX: Download